PISKEL KYLE

CIK 00017806621 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780662

Recent Transactions

35 trades

Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-12−4,290→ 4,291 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$18.00/sh−4,290→ 216,637 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$12.14/sh+4,290→ 220,927 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-28$19.50/sh−162,820→ 216,637 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-28−11,980→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-28−3,750→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-28−94,384→ 8,581 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-28$6.55/sh+11,980→ 281,323 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-28$7.80/sh+3,750→ 285,073 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-28$12.14/sh+94,384→ 379,457 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-17$14.05/sh−238→ 269,343 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-05-16$8.89/sh−1,929→ 269,581 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-05-16$8.89/sh−1,929→ 277,396 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-05-15+7,815→ 279,325 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2025-03-14−2,500→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-14$6.32/sh+2,500→ 271,510 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.97/sh−3,103→ 276,227 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−253→ 275,974 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−6,964→ 269,010 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+125,000→ 279,330 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-11-18$4.98/sh−248→ 154,330 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-05-15+31,260→ 154,578 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−7,727→ 123,318 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+43,740→ 131,045 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-11-16$4.13/sh−259→ 87,305 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.57/sh−3,300→ 87,793 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+43,735→ 91,093 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.58/sh−229→ 87,564 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-11-16$8.87/sh−959→ 46,706 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-11-16$8.87/sh−307→ 47,358 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−220→ 47,665 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+102,965→ 102,965 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+41,186→ 47,885 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-11-15+9,592→ 9,592 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-11-15+3,837→ 6,699 total

Companies

Adaptive Biotechnologies Corp
Chief Financial Officer
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVE E

SEATTLE, WA, 98109

View on SEC.gov